Sun Pharmaceuticals Ltd reported Total revenue for Q4 FY23 of ₹10,931 Crore, up from ₹9,447 Crore year on year depicting a growth of 16%. Consolidated Net Profit of ₹1,984 Crore, up 187% from -(₹2,227) Crore in the same quarter of the previous year. The Earnings per Share is ₹8.3, up 187% from -(₹9.49) in the same quarter of the previous year.
Sun Pharmaceuticals Ltd Q4FY23 results out, revenue grows by 16%
Related Post
- Sona BLW Precision Forgings Limited Q4 FY24 Earnings Conference Call Insights
Key highlights from Sona BLW Precision Forgings Limited (SONACOMS) Q4 FY24 Earnings Concall BEV Revenue…
-
Raymond Ltd Q4FY24; 17% rise in Profits
Raymond Limited incorporated in 1925 is a diversified group with interests in Textile & Apparel…
-
Tatva Chintan Pharma Chem Ltd Q4FY24; 43% fall in Profits
Tatva Chintan Pharma Chem Limited was incorporated in 1996 and it is a manufacturer of…